Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Enterococcus faecium TIR-Domain Genes Are Part of a Gene Cluster Which Promotes Bacterial Survival in Blood.

Wagner TM, Janice J, Paganelli FL, Willems RJ, Askarian F, Pedersen T, Top J, de Haas C, van Strijp JA, Johannessen M, Hegstad K.

Int J Microbiol. 2018 Dec 3;2018:1435820. doi: 10.1155/2018/1435820. eCollection 2018.

2.

Complement Factor H and Apolipoprotein E Participate in Regulation of Inflammation in THP-1 Macrophages.

Nissilä E, Hakala P, Leskinen K, Roig A, Syed S, Van Kessel KPM, Metso J, De Haas CJC, Saavalainen P, Meri S, Chroni A, Van Strijp JAG, Öörni K, Jauhiainen M, Jokiranta TS, Haapasalo K.

Front Immunol. 2018 Nov 21;9:2701. doi: 10.3389/fimmu.2018.02701. eCollection 2018.

3.

Staphylococcus aureus toxin LukSF dissociates from its membrane receptor target to enable renewed ligand sequestration.

Haapasalo K, Wollman AJM, de Haas CJC, van Kessel KPM, van Strijp JAG, Leake MC.

FASEB J. 2019 Mar;33(3):3807-3824. doi: 10.1096/fj.201801910R. Epub 2018 Dec 3.

4.

Molecular basis determining species specificity for TLR2 inhibition by staphylococcal superantigen-like protein 3 (SSL3).

Koymans KJ, Feitsma LJ, Bisschop A, Huizinga EG, van Strijp JAG, de Haas CJC, McCarthy AJ.

Vet Res. 2018 Nov 28;49(1):115. doi: 10.1186/s13567-018-0609-8.

5.

Streptococcal Lancefield polysaccharides are critical cell wall determinants for human Group IIA secreted phospholipase A2 to exert its bactericidal effects.

van Hensbergen VP, Movert E, de Maat V, Lüchtenborg C, Le Breton Y, Lambeau G, Payré C, Henningham A, Nizet V, van Strijp JAG, Brügger B, Carlsson F, McIver KS, van Sorge NM.

PLoS Pathog. 2018 Oct 15;14(10):e1007348. doi: 10.1371/journal.ppat.1007348. eCollection 2018 Oct.

6.

Publisher Correction: Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidin.

Tromp AT, Van Gent M, Abrial P, Martin A, Jansen JP, De Haas CJC, Van Kessel KPM, Bardoel BW, Kruse E, Bourdonnay E, Boettcher M, McManus MT, Day CJ, Jennings MP, Lina G, Vandenesch F, Van Strijp JAG, Lebbink RJ, Haas PA, Henry T, Spaan AN.

Nat Microbiol. 2018 Oct;3(10):1187. doi: 10.1038/s41564-018-0247-y.

PMID:
30177744
7.

Staphylococcal superantigen-like protein 13 activates neutrophils via formyl peptide receptor 2.

Zhao Y, van Kessel KPM, de Haas CJC, Rogers MRC, van Strijp JAG, Haas PA.

Cell Microbiol. 2018 Nov;20(11):e12941. doi: 10.1111/cmi.12941. Epub 2018 Sep 17.

8.

Human skin commensals augment Staphylococcus aureus pathogenesis.

Boldock E, Surewaard BGJ, Shamarina D, Na M, Fei Y, Ali A, Williams A, Pollitt EJG, Szkuta P, Morris P, Prajsnar TK, McCoy KD, Jin T, Dockrell DH, van Strijp JAG, Kubes P, Renshaw SA, Foster SJ.

Nat Microbiol. 2018 Aug;3(8):881-890. doi: 10.1038/s41564-018-0198-3. Epub 2018 Jul 16.

9.

Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidin.

Tromp AT, Van Gent M, Abrial P, Martin A, Jansen JP, De Haas CJC, Van Kessel KPM, Bardoel BW, Kruse E, Bourdonnay E, Boettcher M, McManus MT, Day CJ, Jennings MP, Lina G, Vandenesch F, Van Strijp JAG, Lebbink RJ, Haas PA, Henry T, Spaan AN.

Nat Microbiol. 2018 Jun;3(6):708-717. doi: 10.1038/s41564-018-0159-x. Epub 2018 May 7. Erratum in: Nat Microbiol. 2018 Oct;3(10):1187.

PMID:
29736038
10.

Identification and structural characterization of a novel myeloperoxidase inhibitor from Staphylococcus delphini.

Ploscariu NT, de Jong NWM, van Kessel KPM, van Strijp JAG, Geisbrecht BV.

Arch Biochem Biophys. 2018 May 1;645:1-11. doi: 10.1016/j.abb.2018.03.007. Epub 2018 Mar 7.

PMID:
29524428
11.

Identification of a staphylococcal complement inhibitor with broad host specificity in equid Staphylococcus aureus strains.

de Jong NWM, Vrieling M, Garcia BL, Koop G, Brettmann M, Aerts PC, Ruyken M, van Strijp JAG, Holmes M, Harrison EM, Geisbrecht BV, Rooijakkers SHM.

J Biol Chem. 2018 Mar 23;293(12):4468-4477. doi: 10.1074/jbc.RA117.000599. Epub 2018 Feb 5.

12.

A structurally dynamic N-terminal region drives function of the staphylococcal peroxidase inhibitor (SPIN).

de Jong NWM, Ploscariu NT, Ramyar KX, Garcia BL, Herrera AI, Prakash O, Katz BB, Leidal KG, Nauseef WM, van Kessel KPM, van Strijp JAG, Geisbrecht BV.

J Biol Chem. 2018 Feb 16;293(7):2260-2271. doi: 10.1074/jbc.RA117.000134. Epub 2018 Jan 5.

13.

The Staphylococcus aureus superantigen SElX is a bifunctional toxin that inhibits neutrophil function.

Tuffs SW, James DBA, Bestebroer J, Richards AC, Goncheva MI, O'Shea M, Wee BA, Seo KS, Schlievert PM, Lengeling A, van Strijp JA, Torres VJ, Fitzgerald JR.

PLoS Pathog. 2017 Sep 7;13(9):e1006461. doi: 10.1371/journal.ppat.1006461. eCollection 2017 Sep.

14.

The TLR2 Antagonist Staphylococcal Superantigen-Like Protein 3 Acts as a Virulence Factor to Promote Bacterial Pathogenicity in vivo.

Koymans KJ, Goldmann O, Karlsson CAQ, Sital W, Thänert R, Bisschop A, Vrieling M, Malmström J, van Kessel KPM, de Haas CJC, van Strijp JAG, Medina E.

J Innate Immun. 2017;9(6):561-573. doi: 10.1159/000479100. Epub 2017 Sep 1.

15.

Immune evasion by a staphylococcal inhibitor of myeloperoxidase.

de Jong NWM, Ramyar KX, Guerra FE, Nijland R, Fevre C, Voyich JM, McCarthy AJ, Garcia BL, van Kessel KPM, van Strijp JAG, Geisbrecht BV, Haas PA.

Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):9439-9444. doi: 10.1073/pnas.1707032114. Epub 2017 Aug 14.

16.

Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors.

Spaan AN, van Strijp JAG, Torres VJ.

Nat Rev Microbiol. 2017 Jul;15(7):435-447. doi: 10.1038/nrmicro.2017.27. Epub 2017 Apr 19. Review.

17.

Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria.

Amdahl H, Haapasalo K, Tan L, Meri T, Kuusela PI, van Strijp JA, Rooijakkers S, Jokiranta TS.

PLoS One. 2017 Mar 8;12(3):e0172675. doi: 10.1371/journal.pone.0172675. eCollection 2017.

18.

Fluorescent reporters for markerless genomic integration in Staphylococcus aureus.

de Jong NW, van der Horst T, van Strijp JA, Nijland R.

Sci Rep. 2017 Mar 7;7:43889. doi: 10.1038/srep43889.

19.

Identification of LukPQ, a novel, equid-adapted leukocidin of Staphylococcus aureus.

Koop G, Vrieling M, Storisteanu DM, Lok LS, Monie T, van Wigcheren G, Raisen C, Ba X, Gleadall N, Hadjirin N, Timmerman AJ, Wagenaar JA, Klunder HM, Fitzgerald JR, Zadoks R, Paterson GK, Torres C, Waller AS, Loeffler A, Loncaric I, Hoet AE, Bergström K, De Martino L, Pomba C, de Lencastre H, Ben Slama K, Gharsa H, Richardson EJ, Chilvers ER, de Haas C, van Kessel K, van Strijp JA, Harrison EM, Holmes MA.

Sci Rep. 2017 Jan 20;7:40660. doi: 10.1038/srep40660.

20.

LukMF' is the major secreted leukocidin of bovine Staphylococcus aureus and is produced in vivo during bovine mastitis.

Vrieling M, Boerhout EM, van Wigcheren GF, Koymans KJ, Mols-Vorstermans TG, de Haas CJ, Aerts PC, Daemen IJ, van Kessel KP, Koets AP, Rutten VP, Nuijten PJ, van Strijp JA, Benedictus L.

Sci Rep. 2016 Nov 25;6:37759. doi: 10.1038/srep37759.

21.

Staphylococcus aureus SaeR/S-regulated factors reduce human neutrophil reactive oxygen species production.

Guerra FE, Addison CB, de Jong NW, Azzolino J, Pallister KB, van Strijp JA, Voyich JM.

J Leukoc Biol. 2016 Nov;100(5):1005-1010. Epub 2016 Jun 22.

22.

Serine-Aspartate Repeat Protein D Increases Staphylococcus aureus Virulence and Survival in Blood.

Askarian F, Uchiyama S, Valderrama JA, Ajayi C, Sollid JU, van Sorge NM, Nizet V, van Strijp JA, Johannessen M.

Infect Immun. 2016 Dec 29;85(1). pii: e00559-16. doi: 10.1128/IAI.00559-16. Print 2017 Jan.

23.

Staphylococcal Superantigen-Like Protein 1 and 5 (SSL1 & SSL5) Limit Neutrophil Chemotaxis and Migration through MMP-Inhibition.

Koymans KJ, Bisschop A, Vughs MM, van Kessel KP, de Haas CJ, van Strijp JA.

Int J Mol Sci. 2016 Jul 5;17(7). pii: E1072. doi: 10.3390/ijms17071072.

24.

Staphylococcal Immune Evasion Proteins: Structure, Function, and Host Adaptation.

Koymans KJ, Vrieling M, Gorham RD Jr, van Strijp JAG.

Curr Top Microbiol Immunol. 2017;409:441-489. doi: 10.1007/82_2015_5017.

PMID:
26919864
25.

Staphylococcus aureus protects its immune-evasion proteins against degradation by neutrophil serine proteases.

Stapels DA, Kuipers A, von Köckritz-Blickwede M, Ruyken M, Tromp AT, Horsburgh MJ, de Haas CJ, van Strijp JA, van Kessel KP, Rooijakkers SH.

Cell Microbiol. 2016 Apr;18(4):536-45. doi: 10.1111/cmi.12528. Epub 2015 Oct 23.

PMID:
26418545
26.

Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes.

Spaan AN, Reyes-Robles T, Badiou C, Cochet S, Boguslawski KM, Yoong P, Day CJ, de Haas CJ, van Kessel KP, Vandenesch F, Jennings MP, Le Van Kim C, Colin Y, van Strijp JA, Henry T, Torres VJ.

Cell Host Microbe. 2015 Sep 9;18(3):363-70. doi: 10.1016/j.chom.2015.08.001. Epub 2015 Aug 27.

27.

Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3).

Koymans KJ, Feitsma LJ, Brondijk TH, Aerts PC, Lukkien E, Lössl P, van Kessel KP, de Haas CJ, van Strijp JA, Huizinga EG.

Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):11018-23. doi: 10.1073/pnas.1502026112. Epub 2015 Aug 17.

28.

Complement activity is associated with disease severity in multifocal motor neuropathy.

Vlam L, Cats EA, Harschnitz O, Jansen MD, Piepers S, Veldink JH, Franssen H, Stork AC, Heezius E, Rooijakkers SH, Herpers BL, van Strijp JA, van den Berg LH, van der Pol WL.

Neurol Neuroimmunol Neuroinflamm. 2015 Jun 25;2(4):e119. doi: 10.1212/NXI.0000000000000119. eCollection 2015 Aug.

29.

Versatile vector suite for the extracytoplasmic production and purification of heterologous His-tagged proteins in Lactococcus lactis.

Neef J, Milder FJ, Koedijk DG, Klaassens M, Heezius EC, van Strijp JA, Otto A, Becher D, van Dijl JM, Buist G.

Appl Microbiol Biotechnol. 2015 Nov;99(21):9037-48. doi: 10.1007/s00253-015-6778-8. Epub 2015 Jul 10.

30.

Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors.

Spaan AN, Schiepers A, de Haas CJ, van Hooijdonk DD, Badiou C, Contamin H, Vandenesch F, Lina G, Gerard NP, Gerard C, van Kessel KP, Henry T, van Strijp JA.

J Immunol. 2015 Aug 1;195(3):1034-43. doi: 10.4049/jimmunol.1500604. Epub 2015 Jun 19.

31.

Bovine Staphylococcus aureus Secretes the Leukocidin LukMF' To Kill Migrating Neutrophils through CCR1.

Vrieling M, Koymans KJ, Heesterbeek DA, Aerts PC, Rutten VP, de Haas CJ, van Kessel KP, Koets AP, Nijland R, van Strijp JA.

MBio. 2015 Jun 4;6(3):e00335. doi: 10.1128/mBio.00335-15.

32.

Microenvironment involved in FPR1 expression by human glioblastomas.

Boer JC, van Marion DM, Joseph JV, Kliphuis NM, Timmer-Bosscha H, van Strijp JA, de Vries EG, den Dunnen WF, Kruyt FA, Walenkamp AM.

J Neurooncol. 2015 May;123(1):53-63. doi: 10.1007/s11060-015-1777-2. Epub 2015 Apr 19.

33.

Effective Neutrophil Phagocytosis of Aspergillus fumigatus Is Mediated by Classical Pathway Complement Activation.

Braem SG, Rooijakkers SH, van Kessel KP, de Cock H, Wösten HA, van Strijp JA, Haas PJ.

J Innate Immun. 2015;7(4):364-74. doi: 10.1159/000369493. Epub 2015 Feb 10.

34.

Bright fluorescent Streptococcus pneumoniae for live-cell imaging of host-pathogen interactions.

Kjos M, Aprianto R, Fernandes VE, Andrew PW, van Strijp JA, Nijland R, Veening JW.

J Bacteriol. 2015 Mar;197(5):807-18. doi: 10.1128/JB.02221-14. Epub 2014 Dec 15.

35.

The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors.

Spaan AN, Vrieling M, Wallet P, Badiou C, Reyes-Robles T, Ohneck EA, Benito Y, de Haas CJ, Day CJ, Jennings MP, Lina G, Vandenesch F, van Kessel KP, Torres VJ, van Strijp JA, Henry T.

Nat Commun. 2014 Nov 11;5:5438. doi: 10.1038/ncomms6438.

36.

Pathogens under stress.

van Strijp JA, Bitter W.

FEMS Microbiol Rev. 2014 Nov;38(6):1089-90. doi: 10.1111/1574-6976.12090. No abstract available.

37.

Neutrophil-Mediated Phagocytosis of Staphylococcus aureus.

van Kessel KP, Bestebroer J, van Strijp JA.

Front Immunol. 2014 Sep 26;5:467. doi: 10.3389/fimmu.2014.00467. eCollection 2014. Review.

38.

Recognition of LPS by TLR4: potential for anti-inflammatory therapies.

Nijland R, Hofland T, van Strijp JA.

Mar Drugs. 2014 Jul 23;12(7):4260-73. doi: 10.3390/md12074260.

39.

Staphylococcus aureus proteins SSL6 and SElX interact with neutrophil receptors as identified using secretome phage display.

Fevre C, Bestebroer J, Mebius MM, de Haas CJ, van Strijp JA, Fitzgerald JR, Haas PJ.

Cell Microbiol. 2014 Nov;16(11):1646-65. doi: 10.1111/cmi.12313. Epub 2014 Jun 19.

PMID:
24840181
40.

Pseudomonas syringae evades host immunity by degrading flagellin monomers with alkaline protease AprA.

Pel MJ, van Dijken AJ, Bardoel BW, Seidl MF, van der Ent S, van Strijp JA, Pieterse CM.

Mol Plant Microbe Interact. 2014 Jul;27(7):603-10. doi: 10.1094/MPMI-02-14-0032-R.

41.

A Staphylococcus aureus TIR domain protein virulence factor blocks TLR2-mediated NF-κB signaling.

Askarian F, van Sorge NM, Sangvik M, Beasley FC, Henriksen JR, Sollid JU, van Strijp JA, Nizet V, Johannessen M.

J Innate Immun. 2014;6(4):485-98. doi: 10.1159/000357618. Epub 2014 Jan 25.

42.

Entrapment exploited.

van Strijp JA, Rooijakkers SH.

Trends Microbiol. 2014 Feb;22(2):55-7. doi: 10.1016/j.tim.2013.12.010. Epub 2013 Dec 31.

PMID:
24387831
43.

Studying interactions of Staphylococcus aureus with neutrophils by flow cytometry and time lapse microscopy.

Surewaard BG, van Strijp JA, Nijland R.

J Vis Exp. 2013 Jul 17;(77):e50788. doi: 10.3791/50788.

44.

EsiB, a novel pathogenic Escherichia coli secretory immunoglobulin A-binding protein impairing neutrophil activation.

Pastorello I, Rossi Paccani S, Rosini R, Mattera R, Ferrer Navarro M, Urosev D, Nesta B, Lo Surdo P, Del Vecchio M, Rippa V, Bertoldi I, Gomes Moriel D, Laarman AJ, van Strijp JA, Daura X, Pizza M, Serino L, Soriani M.

MBio. 2013 Jul 23;4(4). pii: e00206-13. doi: 10.1128/mBio.00206-13.

45.

Distinct localization of the complement C5b-9 complex on Gram-positive bacteria.

Berends ET, Dekkers JF, Nijland R, Kuipers A, Soppe JA, van Strijp JA, Rooijakkers SH.

Cell Microbiol. 2013 Dec;15(12):1955-68. doi: 10.1111/cmi.12170. Epub 2013 Aug 13.

PMID:
23869880
46.

Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion.

Amdahl H, Jongerius I, Meri T, Pasanen T, Hyvärinen S, Haapasalo K, van Strijp JA, Rooijakkers SH, Jokiranta TS.

J Immunol. 2013 Aug 15;191(4):1775-84. doi: 10.4049/jimmunol.1300638. Epub 2013 Jul 17.

47.

Neutrophils versus Staphylococcus aureus: a biological tug of war.

Spaan AN, Surewaard BG, Nijland R, van Strijp JA.

Annu Rev Microbiol. 2013;67:629-50. doi: 10.1146/annurev-micro-092412-155746. Epub 2013 Jul 3. Review.

PMID:
23834243
48.

Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcγR antagonists that inhibit IgG-mediated effector functions.

Stemerding AM, Köhl J, Pandey MK, Kuipers A, Leusen JH, Boross P, Nederend M, Vidarsson G, Weersink AY, van de Winkel JG, van Kessel KP, van Strijp JA.

J Immunol. 2013 Jul 1;191(1):353-62. doi: 10.4049/jimmunol.1203243. Epub 2013 Jun 5.

49.

The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors.

Spaan AN, Henry T, van Rooijen WJM, Perret M, Badiou C, Aerts PC, Kemmink J, de Haas CJC, van Kessel KPM, Vandenesch F, Lina G, van Strijp JAG.

Cell Host Microbe. 2013 May 15;13(5):584-594. doi: 10.1016/j.chom.2013.04.006.

50.

Pneumococcal immune evasion: ZmpC inhibits neutrophil influx.

Surewaard BG, Trzciński K, Jacobino SR, Hansen IS, Vughs MM, Sanders EA, van der Ende A, van Strijp JA, de Haas CJ.

Cell Microbiol. 2013 Oct;15(10):1753-65. doi: 10.1111/cmi.12147. Epub 2013 May 3.

PMID:
23601501

Supplemental Content

Loading ...
Support Center